China Medical Technologies has completed its previously announced acquisition of the entire interest in Beijing Bio-Ekon Biotechnology Co., Ltd.
The acquisition is expected to strengthen the China Medical Technologies' position in advanced IVD market in China.
China Medical Technologies is a China-based medical device company that develops, manufactures and markets advanced IVD products using Enhanced Chemiluminescence technology and Fluorescent in situ Hybridization technology, to detect and monitor various diseases and disorders, and products using High Intensity Focused Ultrasound for the treatment of solid cancers and benign tumors.
Founded in 1999, BBE commenced business in selling ELISA IVD products in China. In 2006, BBE launched its first semi-automatic ECLIA analyzer and related reagents upon receiving approval from the State Food and Drug Administration. BBE has sales offices in Beijing, Guangzhou, Wuhan, Qingdao and Chengdu to conduct direct sales and manage distributors in selling its products to over 800 hospitals in China.